Darwin Cell Biology appointed Dr. Mi Liu as Chief Scientific Officer!

Article Summary.

On the morning of August 27, 2024, Beijing Darwin Cell Biotechnology Co., Ltd. held a short but grand appointment ceremony in the starting meeting room of its headquarters, officially appointing [...]

On the morning of August 27, 2024, Beijing Darwin Cell Biotechnology Co., Ltd. held a short but grand appointment ceremony in the starting meeting room of its headquarters, and formally appointed Dr. Liu Mi as the company's Chief Scientific Officer (CSO), and this appointment took effect from August 14, 2024 onwards.

Since 2020, Dr. Liu Mi, as the head of the basic research project between Soochow University School of Pharmacy and Darwin, initiated the cooperation project between the two sides; in the following year, with his deep academic attainments and unlimited enthusiasm for scientific exploration, he officially joined Darwin Cell Biology as a researcher. After four years of in-depth integration and joint growth, Dr. Liu Mi not only has a deep understanding of Darwin's advanced technology platform, but also has full confidence in its potential for practical application.

After Dr. Liu Mi becomes the company's Chief Science Officer, he will support the company's R&D independently of the project department, and at the same time continue to solidify the research technology results and optimize the R&D process, improve the core competitiveness of the R&D team, and help the business department to improve efficiency.

Yu Wang, Chairman of the Board of Directors, said: "In Darwin, a fertile ground for exploration and innovation, our Chief Science Officer is not only a leader in the field of scientific research, but also a powerful engine to drive the company forward. He must be physically strong and energetic, as true scientific discoveries are often the result of tireless effort and sweat. This requires them not only to be in the game, deep into the front line of scientific research, and work side by side with team members, but also to have a pair of keen eyes, constantly catching the aura of science in the smallest details, and making countless discoveries and verifications until the mysteries of science are unveiled."

"Darwin cherished much more than the specialized skills of scientists, but also their passion for scientific research, their curiosity about the world, their keenness to pick up every subtle clue, and their demonstrated ability to integrate excellently in diverse teams. At the same time, we appreciate scientists who are able to cross disciplinary boundaries and embrace the intersection of knowledge with an open and inclusive mindset. At Darwin, to become a Chief Science Officer is to take on the responsibility and mission of leading the direction of scientific research, facilitating the convergence of disciplines, and driving corporate innovation."

"With his rich entrepreneurial background, Dr. Mi Liu has a deeper understanding and insight into corporate goals. His experience as a doctoral supervisor at a university has given him a rigorous research attitude and superb teaching methods. We are confident that Dr. Liu Mi will shine on the Darwin stage and lead the team to write a new chapter of Darwin together."

Dr. Mi Liu delivered a sincere and passionate speech: "I am deeply honored to join the dynamic and innovative family of Darwin Cell Biologics as Chief Scientific Officer. This is not only a recognition of my personal academic achievements, but also a great mission for me to lead the company in scientific research and innovation. I will do my best to lead the team to accelerate the translation and application of scientific research results based on the company's powerful platform and resources. At the same time, I am looking forward to growing with my team members and continuously improving our scientific research capability and technology level. Thank you for the trust and support given by the company, I will live up to the expectations!"

Darwin Cell Biology warmly welcomes and highly looks forward to the joining of Dr. Mi Liu. Dr. Liu Mi's joining will undoubtedly bring Darwin Cell Biologics more cutting-edge scientific research concepts and strong scientific research technical support; the company will continue to uphold the spirit of innovation, openness, and cooperation, exploring the infinite possibilities of biomedicine, and contributing more power to the cause of human health.

Profile of Dr. Mi Liu, Chief Scientific Officer (CSO)

He is a Distinguished Professor in the Department of Pharmacy, College of Pharmacy, Soochow University, and a Ph. D. from the Department of Pharmacy, Swiss Federal Institute of Technology in Zurich (ETH Zürich), and a postdoctoral fellowship from the Department of Immunology, Harvard Medical School, with a focus on prophylactic and therapeutic cancer vaccines, T-cell therapeutics, and assays. He has been awarded the Mary K. Iacocca Fellowship at Harvard Medical School twice, and has been published as first or corresponding author in Nature Communications, Advanced Materials, Advanced Science, Advanced Functional Materials, Progress in Polymer Science, and other international journals. Progress in Polymer Science, etc. As the first inventor, he has applied for more than 60 international patents and domestic patents for cancer vaccines, T-cell detection and therapy, of which 18 have been authorized.